Crossmark

Accounting for confounding by time, early intervention adoption, and time-varying effect modification in the design and analysis of stepped-wedge designs: application to a proposed study design to reduce opioid-related mortality

Crossref DOI link: https://doi.org/10.1186/s12874-021-01229-6

Published Online: 2021-03-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rennert, Lior http://orcid.org/0000-0001-5275-7273
Heo, Moonseong

Litwin, Alain H.

Gruttola, Victor De
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (R37 51164)

National Institute on Drug Abuse (R01DA034086)

National Institute on Drug Abuse (R01DA034086)

Patient-Centered Outcomes Research Institute (HPC-1503-28122)

Patient-Centered Outcomes Research Institute (HPC-1503-28122)
License Information

Text and Data Mining valid from 2021-03-16

Version of Record valid from 2021-03-16
More Information

Article History

Received: 29 October 2020

Accepted: 9 February 2021

First Online: 16 March 2021

Ethics approval and consent to participate

: No ethical approval or consent was required for this simulation study based on a proposed trial design.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below